MIPRIP
MIPRIP predicts regulator–target interactions using a Mixed Integer Linear Programming approach to model gene regulatory networks and identify regulators of the telomerase reverse transcriptase gene TERT across multiple human cancer types.
Key Features:
- Mixed Integer Linear Programming: Applies a Mixed Integer Linear Programming (MILP) framework to predict interactions between regulators and target genes.
- Gene Regulatory Network Construction: Constructs generic human and mouse gene regulatory networks by integrating regulator binding information from multiple sources.
- Identification of Regulators: Identifies common and cancer-type-specific regulators of TERT by analyzing data across 19 human cancer types.
- Validation of Predictions: Validates predicted regulatory relationships against known interactions, exemplified by ETS1 regulation of TERT in melanomas with specific promoter mutations.
Scientific Applications:
- Cancer research: Dissects TERT regulatory mechanisms to provide insights into tumorigenesis and potential therapeutic targets.
- Comparative regulatory analysis: Reveals cancer-type-specific regulatory interactions by comparing regulatory landscapes across different cancers.
- General gene regulation studies: Models gene regulation across various biological conditions beyond oncology.
Methodology:
Prediction uses a Mixed Integer Linear Programming approach, integration of regulator binding information from multiple sources to build generic human and mouse gene regulatory networks, analysis across 19 human cancer types, and validation against known regulatory interactions such as ETS1 regulation of TERT in melanomas with specific promoter mutations.
Topics
Details
- Tool Type:
- library
- Programming Languages:
- R
- Added:
- 1/18/2021
- Last Updated:
- 2/24/2021
Operations
Publications
Poos AM, Kordaß T, Kolte A, Ast V, Oswald M, Rippe K, König R. Modelling TERT regulation across 19 different cancer types based on the MIPRIP 2.0 gene regulatory network approach. BMC Bioinformatics. 2019;20(1). doi:10.1186/s12859-019-3323-2. PMID:31888467. PMCID:PMC6937852.